Chengdu Kanghong Pharmaceutical Group (002773)

Chengdu Kanghong Pharmaceutical Group (002773)

$ 10

Trading Risk Analysis

English Version

Date : 1 Jan 2021


Chengdu Kanghong Pharmaceutical Group Co., Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent medicines, chemical drugs and biological products. The Company?s main products include Conbercept Ophthalmic Injection, Songling capsules conducive to blood vessels, Keluoxin capsules, venlafaxine hydrochloride capsules and sustained release tablets, aripiprazole tablets and orally disintegrating tablets, mosapride citrate tablets and dispersible tablets, dexzopiclone tablets, Shuganjieyu capsules, Danshu capsules and Yiqing capsules, among others. The Company distributes its products in domestic market.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner